✦ LIBER ✦

In vivo drug discovery in the zebrafish

✍ Scribed by Zon, Leonard I.; Peterson, Randall T.

Book ID: 109949691
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 372 KB
Volume: 4
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd1606

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Zon, Leonard I.; Peterson, Randall T. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 372 KB

The zebrafish has become a widely used model organism because of its fecundity, its morphological and physiological similarity to mammals, the existence of many genomic tools and the ease with which large, phenotype-based screens can be performed. Because of these attributes, the zebrafish might als

Model Organisms in Drug Discovery || Lip

Model Organisms in Drug Discovery || Lipid Metabolism and Signaling in Zebrafish

✍ Carroll, Pamela M.; Fitzgerald, Kevin 📂 Article 📅 2003 🏛 John Wiley & Sons, Ltd 🌐 English ⚖ 354 KB 👁 2 views

Predicting in vivo drug interactions fro

Predicting in vivo drug interactions from in vitro drug discovery data

✍ Wienkers, Larry C.; Heath, Timothy G. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 442 KB

In Vivo mouse imaging and spectroscopy i

In Vivo mouse imaging and spectroscopy in drug discovery

✍ Nicolau Beckmann; Rainer Kneuer; Hans-Ulrich Gremlich; Harry Karmouty-Quintana; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 859 KB

Zebrafish: an emerging technology for in

Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery

✍ T P Barros; W K Alderton; H M Reynolds; A G Roach; S Berghmans 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 290 KB

In vivo drug target discovery: identifyi

In vivo drug target discovery: identifying the best targets from the genome

✍ D.Wade Walke; Chunsheng Han; Joseph Shaw; Elisabeth Wann; Brian Zambrowicz; Arth 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 81 KB

A vast number of genes of unknown function threaten to clog drug discovery pipelines. To develop therapeutic products from novel genomic targets, it will be necessary to correlate biology with gene sequence information. Industrialized mouse reverse genetics is being used to determine gene function i